Development of an Active Site Peptide Analog of α-Fetoprotein That Prevents Breast Cancer

被引：11

作者：

Jacobson, Herbert I. ^{[1
,3
]}

Andersen, Thomas T. ^{[2
]}

Bennett, James A. ^{[3
]}

机构：

[1] Albany Med Coll, Dept Obstet & Gynecol, Albany, NY 12208 USA

[2] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA

[3] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA

来源：

CANCER PREVENTION RESEARCH | 2014年 / 7卷 / 06期

关键词：

ESTROGEN-SENSITIVE CELLS; MAMMARY-TUMOR CELLS; GROWTH-INHIBITION; MATERNAL SERUM; SECRETING HEPATOMA; MULTIPLE BIRTHS; PROBABLE ROLE; TWIN BIRTHS; RISK; RATS;

D O I：

10.1158/1940-6207.CAPR-13-0405

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epidemiologic studies associate elevated maternal serum levels of alpha-fetoprotein (AFP) with reduced breast cancer risk for parous women. Laboratory studies demonstrate direct anti-breast cancer activity of AFP. Here, we review the development of a small cyclic peptide that is an active site analog of AFP, referred to as AFPep, which is composed exclusively of amino acids, is orally active, has no discernable toxicity, and is effective for the treatment and prevention of breast cancer in animal models. (C)2014 AACR.

引用

页码：565 / 573

页数：9

共 50 条

[21] Development of active affibody aggregates induced by a self-assembling peptide for high sensitive detection of alpha-fetoprotein
Liu, Juanjuan
Jiang, Yi
Chen, Xi
Chen, Lin
Zhang, Xiaohan
Cui, Dongxu
Li, Yuyin
Liu, Zhenxing
Zhao, Qing
Diao, Aipo
CHEMICAL ENGINEERING JOURNAL, 2022, 436
[22] ISOLATION OF ACTIVE SITE PEPTIDE OF ALPHA CHYMOTRYPSIN
ONG, EB
SHAW, E
SCHOELLM.G
FEDERATION PROCEEDINGS, 1964, 23 (2P1) : 315 - &
[23] Structural modeling of the active site of peptide deformylase
Spiropulos, Nicholas
Brown, Eric
Allen, Kate
Sullivan, Mallory
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[24] DEVELOPMENT OF ERIBULIN, A MACROCYCLIC KETONE ANALOG OF HALICHONDRIN B, FOR ADVANCED BREAST CANCER
Littlefield, Bruce A.
ANTICANCER RESEARCH, 2014, 34 (10) : 6034 - 6034
[25] Development of an α-fetoprotein derived peptide-based theranostic agent for specific targeting of estrogen receptor positive breast cancers
Okarvi, Subhani
Aljammaz, Ibrahim
JOURNAL OF NUCLEAR MEDICINE, 2017, 58
[26] Breast cancer vaccine prevents recurrence
Brower, Vicki
EUROPEAN JOURNAL OF CANCER, 2008, 44 (06) : 770 - 770
[27] Development and Characterization of a Peptide-Bisphosphonate Nanoparticle for the Treatment of Breast Cancer
Glass, Kimberley
Fines, Cory
Coulter, Paula
Jena, Lynn
Mccarthy, Helen O.
Buckley, Niamh
MOLECULAR PHARMACEUTICS, 2024, 21 (10) : 4970 - 4982
[28] Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
Cavaco, Marco
Fraga, Patricia
Valle, Javier
Andreu, David
Castanho, Miguel A. R. B.
Neves, Vera
PHARMACEUTICS, 2021, 13 (11)
[29] Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
Singh, Srishti
Lomelino, Carrie L.
Mboge, Mam Y.
Frost, Susan C.
McKenna, Robert
MOLECULES, 2018, 23 (05):
[30] Probing the active site tryptophan of Staphylococcus aureus thioredoxin with an analog
Englert, Markus
Nakamura, Akiyoshi
Wang, Yane-Shih
Eiler, Daniel
Soell, Dieter
Guo, Li-Tao
NUCLEIC ACIDS RESEARCH, 2015, 43 (22) : 11061 - 11067

← 1 2 3 4 5 →